Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Genmab (GMAB)

  • Event
  • June 23, 2022, 16:02 UTC
  • 10
  • 1 comments

(99% Neutral) Genmab (GMAB) Announces Clinical Development Update (Form 6-K)

Comment Full text

Galapagos NV (GLPG)

  • Event
  • June 23, 2022, 15:21 UTC
  • 10
  • 1 comments

(75% Positive) Galapagos NV (GLPG) Announces Clinical Development Update (Form 6-K)

Comment Full text

Galapagos NV (GLPG)

  • Event
  • June 23, 2022, 15:01 UTC
  • 10
  • 1 comments

(99% Neutral) Galapagos NV (GLPG) Files Form 6-K

Comment Full text

Affimed NV (AFMD)

  • Event
  • June 23, 2022, 11:28 UTC
  • 10
  • 1 comments

(99% Neutral) Affimed NV (AFMD) Announces 2022 Annual General Meeting

Comment Full text

RedHill Biopharma (RDHL)

  • Event
  • June 23, 2022, 11:07 UTC
  • 10
  • 1 comments

(30% Negative) RedHill Biopharma (RDHL) Reports Q2 2022 Financial Results (Form 6-K)

Comment Full text

CureVac (CVAC)

  • Event
  • June 22, 2022, 20:15 UTC
  • 10
  • 1 comments

(99% Neutral) CureVac (CVAC) Announces Clinical Development Update (Form 6-K)

Comment Full text

RedHill Biopharma (RDHL)

  • Event
  • June 22, 2022, 12:00 UTC
  • 10
  • 1 comments

(99% Neutral) RedHill Biopharma (RDHL) Files Form 6-K

Comment Full text

Bioventus Inc (BVS)

  • Event
  • June 21, 2022, 20:59 UTC
  • 11
  • 1 comments

(99% Neutral) Bioventus Inc. (BVS) Files Form 8-K

Comment Full text

Sage Therapeutics Inc (SAGE)

  • Event
  • June 21, 2022, 20:41 UTC
  • 11
  • 1 comments

(99% Neutral) Sage Therapeutics, Inc. (SAGE) Announces New Board Appointment

Comment Full text

Alpine Immune Sciences Inc (was acquired Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) on 10/04/2024) (ALPN)

  • Event
  • June 21, 2022, 20:39 UTC
  • 11
  • 1 comments

(99% Neutral) ALPINE IMMUNE SCIENCES, INC. (ALPN) Announces Regulatory Update

Comment Full text
  • Previous
  • 171
  • 172
  • 173
  • 174
  • 175
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189156)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124509)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin